Sorrento Therapeutics, Inc. (CIK: 0000850261) EDGAR, Information, Filings... CompaniesBIO.Com

Sorrento Therapeutics, Inc.

Mailing address
4955 DIRECTORS PLACE, SAN DIEGO, Delaware, 92121
Phone
858-203-4100
State location
California
State of incorporation
Delaware
Fiscal year end
December 31
SIC
2836 - (CF Office: Office of Life Sciences) BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Filings
N/A

Sorrento Therapeutics, Inc. (CIK: 0000850261) is an American company incorporated in the state of California. Head office is located at 4955 DIRECTORS PLACE, SAN DIEGO, California, 92121. Work in the industry 2836 - (CF Office: Office of Life Sciences) BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES). Sorrento Therapeutics, Inc. is a public company and trade via Over-The-Counter (OTC).

Old names:

QUIKBYTE SOFTWARE INC from 2006-14-Jul to 2009-12-Nov

Owner	Filings	Transaction Date	Type of Owner
Reilly Tammy	0001421335	May-18-2022	director
CZEREPAK ELIZABETH	0001263500	Nov-15-2021	director
Asghar Najjam	0001822126	Aug-18-2020	officer: Chief Financial Officer
Smith Robin L	0001365035	Dec-16-2019	director
Lee Edgar	0001511022	Dec-09-2019	director
SHAH JAISIM	0001242133	Nov-26-2018	director
ZELDIS JEROME B	0001433982	Nov-26-2018	officer: See Remarks
Janda Kim	0001518466	Nov-26-2018	director
Wu Yue Alexander	0001682419	Nov-26-2018	director
Followwill Dorman	0001717947	Nov-26-2018	director
Lemus David	0001717972	Nov-26-2018	director
Shao Jiong	0001720540	Mar-19-2018	officer: Chief Financial Officer
Ji Henry	0001470981	Feb-28-2018	director, officer: See Remarks
Ng George K	0001638744	Feb-28-2018	officer: See Remarks
Ferrigno Dean	0001707226	May-15-2017	officer: Chief Accounting Officer
ABG Innovation-SO Ltd	0001704525	Apr-19-2017	10 percent owner
Asia Pacific MedTech (BVI) Ltd	0001704813	Apr-19-2017	10 percent owner
Gu Nana	0001705658	Apr-19-2017	10 percent owner
Toledano Miranda Jayne	0001686530	Sep-16-2016	officer: EVP-Corporate Development
EBERSOLE DOUGLAS O	0001242112	Jul-11-2016	director
Marth William S	0001549936	Jul-11-2016	director
Deming David H	0001641063	Jul-11-2016	director
Ally Bridge Group Capital Partners II, L.P.	0001609313	Jul-07-2016	10 percent owner
Ally Bridge LB Healthcare Master Fund Ltd	0001667354	Jul-07-2016	10 percent owner
ABG Management Ltd	0001668027	Jul-07-2016	10 percent owner
Ally Bridge LB Management Ltd	0001668028	Jul-07-2016	10 percent owner
Yu Fan	0001668029	Jul-07-2016	10 percent owner
Li Bin	0001668219	Jul-07-2016	10 percent owner
Ally Bridge Group Innovation Capital Partners III, L.P.	0001674513	Jul-07-2016	10 percent owner
ABG SRNE Ltd	0001676083	Jul-07-2016	10 percent owner
ABG II-SO Ltd	0001676141	Jul-07-2016	10 percent owner
Herde Kevin	0001671595	Apr-05-2016	officer: Executive VP and CFO
Chan Soon-Shiong Family Foundation	0001668335	Dec-31-2015	10 percent owner
Su Jeffrey	0001656789	Oct-19-2015	officer: Executive VP and COO
Uy George	0001586890	Sep-18-2015	officer: See Remarks
SOON-SHIONG PATRICK	0001189020	Dec-22-2014	10 percent owner
MP 13 Ventures, LLC	0001629186	Dec-22-2014	10 percent owner
Cambridge Equities, LP	0001629222	Dec-22-2014	10 percent owner
Royal Mike	0001621463	Jun-27-2014	officer: See Remarks
Durand Mark	0001360575	Mar-07-2014	director
LEVITT DANIEL J	0001278711	Jan-30-2014	director
Singh Amar	0001486809	Jan-06-2014	director, officer: See Remarks
Miao Zhenwei	0001605519	Dec-19-2013	officer: Chief Technology Officer
Trieu Vuong	0001587074	Sep-09-2013	director, officer: Chief Scientific Officer
Webb David Ritchie	0001557756	Sep-06-2012	director
Gallagher Cam	0001557832	Sep-06-2012	director
Tang-Liu Diane D S	0001542803	Feb-23-2012	director
Salka Michael Scott	0001542981	Feb-23-2012	director
SCIFRES DONALD R	0001008155	Dec-31-2011	10 percent owner
SCHUH ANTONIUS	0001234883	Feb-16-2010	director, 10 percent owner, officer: Chairman and CEO
HALPRYN GLENN L	0000938439	Feb-05-2010	director
AFTING ERNST-GUENTER	0001234864	Feb-05-2010	director
VINCENT RICHARD G	0001269341	Feb-05-2010	officer: Chief Financial Officer
Lockshin Curtis	0001383556	Feb-05-2010	director
ZANIBONI STEVE	0001234887	Feb-04-2010	director, 10 percent owner
HSIAO JANE PH D	0001188834	Jan-25-2010	director
Rodi Charles P	0001475738	Nov-02-2009	officer: VP, Research & Development
Molsbergen Martina	0001474758	Oct-22-2009	officer: VP, Business Development
Opko Health, Inc.	0000944809	Sep-21-2009	10 percent owner
Shuster Lewis	0001471131	Sep-21-2009	director
Freedman S. James	0001472046	Sep-21-2009	director
STEIN RONALD M	0001034244	Jul-07-2008	director
Weisberg Alan Jay	0001383481	Jul-07-2008	director, officer: CFO
SILVER NOAH M	0001385273	Jul-07-2008	director, officer: VP, Secretary and Treasurer
GLAUSER STEVEN JERRY	0001385272	Jun-02-2008	10 percent owner
BLACKWELL MARGIE L	0001164780	Mar-26-2007	director
KEATING KEVIN R	0001164783	Mar-26-2007	director, officer: CEO, CFO, Pres, Secry, & Treas
ANDREWS JEFF L	0001394292	Mar-26-2007	director
LITTMAN M A	0001126534	Mar-24-2007	other: Former 10% Owner
KI EQUITY PARTNERS V LLC	0001393710	Mar-23-2007	10 percent owner
Ponce Acquisition LLC	0001389707	Feb-02-2007	10 percent owner
WHITING WESLEY F	0001253181	Jan-24-2007	director
Green Redgie T	0001310804	Jan-24-2007	director

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Sorrento Therapeutics, Inc.

Filings	Format	Description	Filed/Effective	File/Film Number
8-K	Document	Current report filing Acc-no: 0001104659-23-115270 (34 Act) Size: 188 KB	Nov-07-2023	001-36150 231384473
8-K	Document	Current report filing Acc-no: 0001104659-23-114354 (34 Act) Size: 681 KB	Nov-03-2023	001-36150 231377463
8-K	Document	Current report filing Acc-no: 0001104659-23-112178 (34 Act) Size: 196 KB	Oct-27-2023	001-36150 231355701
8-K	Document	Current report filing Acc-no: 0001104659-23-107275 (34 Act) Size: 290 KB	Oct-05-2023	001-36150 231312222
SC 13G/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001104659-23-107269 ( Act) Size: 44 KB	Oct-05-2023
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001104659-23-107259 (34 Act) Size: 7 KB	Oct-05-2023	001-38914 231312155
8-K	Document	Current report filing Acc-no: 0001104659-23-103911 (34 Act) Size: 689 KB	Sep-26-2023	001-36150 231281040
SC 13D/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0001104659-23-103904 ( Act) Size: 236 KB	Sep-26-2023
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001104659-23-103527 (34 Act) Size: 8 KB	Sep-25-2023	001-39852 231276120
8-K	Document	Current report filing Acc-no: 0001104659-23-100179 (34 Act) Size: 383 KB	Sep-13-2023	001-36150 231251523
8-K	Document	Current report filing Acc-no: 0001104659-23-096071 (34 Act) Size: 242 KB	Aug-28-2023	001-36150 231217286
8-K	Document	Current report filing Acc-no: 0001104659-23-093768 (34 Act) Size: 10875 KB	Aug-21-2023	001-36150 231187962
SC 13D/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0001193125-23-212733 ( Act) Size: 67 KB	Aug-15-2023
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0000950170-23-041995 (34 Act) Size: 17023 KB	Aug-14-2023	001-36150 231165805
8-K	Document	Current report filing Acc-no: 0001104659-23-089802 (34 Act) Size: 1104 KB	Aug-10-2023	001-36150 231159543
NT 10-Q	Document	Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB Acc-no: 0000950170-23-039079 (34 Act) Size: 31 KB	Aug-07-2023	001-36150 231147813
8-K	Document	Current report filing Acc-no: 0001104659-23-085989 (34 Act) Size: 13737 KB	Aug-01-2023	001-36150 231129445
POS AM	Document	Post-effective amendment to a registration statement that is not immediately effective upon filing Acc-no: 0001104659-23-082080 (33 Act) Size: 717 KB	Jul-18-2023	333-261888 231095072
8-K	Document	Current report filing Acc-no: 0001104659-23-080534 (34 Act) Size: 10700 KB	Jul-13-2023	001-36150 231085710
8-K	Document	Current report filing Acc-no: 0001104659-23-079246 (34 Act) Size: 450 KB	Jul-10-2023	001-36150 231078106

Recent 20 filings. View all Sorrento Therapeutics, Inc. filings

Overall rating 5.0

Aug 22, 2022

Jean Bishop

Very good communication and delivery made within the timeframe I was advised of

Aug 22, 2022

Catherine

Thanks I look forward to using the product to improve my skin tone

Aug 22, 2022

Ryan Storey

Huge help thank you for your help .. y'all make it so much easier

Sorrento Therapeutics, Inc. overview
Sorrento Therapeutics, Inc. job
Sorrento Therapeutics, Inc. stock
Sorrento Therapeutics, Inc. ownership
Sorrento Therapeutics, Inc. CEO
Sorrento Therapeutics, Inc. documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.